Ardent Health, Inc. announced the completion of a public offering of common stock on November 19, 2026. The offering involved the sale of 8,000,000 shares of common stock, par value $0.01 per share, by Selling Stockholders, including EGI-AM Investments, L.L.C., an affiliated entity of Equity Group Investments, and ALH Holdings, LLC, a subsidiary of Ventas, Inc.

The shares were sold to the public at a price of $14.50 per share. The total gross proceeds from the sale were $116,000,000. Ardent Health did not receive any proceeds from the sale of these shares.

In connection with the transaction, the Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares at the public offering price. Additionally, on November 19, 2026, Ardent Health repurchased 1,500,000 shares from the underwriters at a price of $13.7025 per share. This concurrent share repurchase was funded using existing cash on hand, and the underwriters did not receive compensation for these repurchased shares.

The offering was conducted pursuant to a shelf registration statement on Form S-3 (File No. 333-289763) filed with the SEC on August 21, 2025, and declared effective on August 25, 2025.